Abroad the healthcare market place is uniquely different depending upon varying geopolitical and market place factors. Trying to establish strategic partnerships to export quality healthcare either on a for-profit or non-profit basis internationally can be challenging for any U.S. based entity.  

Innovations that seek to broaden the ability to achieve greater efficiency in healthcare delivery often center around ground breaking technologies whose development are tied directly to profitability.  Often, technologies that seek to lessen the burdens placed on the delivery of quality healthcare go undeveloped or underfunded.  Likewise, so to does policy and research initiatives that could lead to vast improvements in the delivery of quality healthcare and whose enactment do not necessarily impact the bottom line in a positive fashion. 

Through the identification of these three major categories, McWilliams Collective has developed a Biotechnology & Healthcare Initiatives Cohesion of Innovations Menu that will seek to address these concerns both domestically and abroad.


healthcare initiatives

home   |   inquiry

Potential clientele of interest:

Any for-profit, not-for-profit, any domestic 501(c) not-for-profit such as but not limited to a charity, foundation, social welfare organization, research institution, not-for-profit healthcare delivery provider,  municipality, governmental agency either domestic or international, NGO, international agency, university, or any organized movement seeking to elevate the global social conscience. 

Biotechnology & Healthcare Initiatives 

Cohesion of Innovations Menu:

A dialogue with potential clientele:

McWilliams Collective designed our Biotechnology & Healthcare Initiatives Cohesion of Innovations Menu specifically to address three categories that are both of immense importance to our collective principals as well as the strategic partners we seek to collaborate with.  

In the United States, the healthcare market place is constantly evolving to achieve greater efficiency.  This evolution is a result of a constantly changing regulatory climate, new healthcare delivery models that seek to address changing market conditions, the rise of new technologies, and an often outdated domestic heatlhcare infrastructure.